Camptosar (irinotecan), the first new drug for colorectal cancer in 40 years

July 1996

You'll also see Camptosar (irinotecan), the first new drug for colorectal cancer in 40 years. From Pharmacia & Upjohn.

It's in the same new class as Hycamtin.

Camptosar will be used as second-line therapy...for cancer that progresses after standard therapy with 5-fluorouracil.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Diabetes Humalog (insulin lispro)
Diabetes taking chromium for diabetes
Diabetes major new study to determine if Type II diabetes can be prevented or delayed
Ophthalmology Xalatan (ZAL-a-ten, latanoprost), a unique eye drop for glaucoma
changes in the package insert for the appetite suppressant Pondimin (fenfluramine)
precaution about using Pondimin with serotonergic drugs
high doses of vitamin E for tardive dyskinesia
Dermatology Retin-A for stretch marks
The FDA just approved Viramune (nevirapine)
Zithromax (azithromycin) is now approved to prevent Mycobacterium avium complex (MAC)
three important HIV tests
new test to MONITOR HIV, Amplicor HIV-1
Gastroenterology Do OTC H2-blockers work better than antacids for heartburn
Hematology & Oncology Several significant new injectable cancer drugs are now hitting the market
Hematology & Oncology Gemzar (GEM-zar, gemcitabine), the first new drug for advanced pancreatic cancer in 30 years
Hematology & Oncology Hycamtin (Hy-CAM-tin, topotecan) for ovarian cancer
Hematology & Oncology Camptosar (irinotecan), the first new drug for colorectal cancer in 40 years